Misato Ito
Impact in
-
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
-
- Rheumatoid Arthritis Research and Therapies
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 7
- Cytokine Signaling Pathways and Interactions 5
- Chemokine receptors and signaling 3
- Immunology 10
- Immune Cell Function and Interaction 4
- Co-authors
- Shohei Shirakami (5 shared papers)Takayuki Inoue (4 shared papers)Yasuyuki Higashi (3 shared papers)Masamichi Inami (5 shared papers)Koji Nakamura (5 shared papers)Masahiro Murakami (5 shared papers)Ayako Moritomo (3 shared papers)Yutaka Nakajima (3 shared papers)
- Journals
- Anticancer Research (3 papers)Cancer Immunology Immunotherapy (3 papers)Chemistry Letters (3 papers)Bioorganic & Medicinal Chemistry (3 papers)International Immunopharmacology (2 papers)
- Partner nations
- Japan
In The Last Decade
Misato Ito
32 papers receiving 342 citations
Peers
Comparison fields: 5 of 58
- Oncology 165
- Rheumatology 75
- Genetics 51
- Immunology 84
- Hematology 32
Countries citing papers authored by Misato Ito
This map shows the geographic impact of Misato Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misato Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misato Ito more than expected).
Fields of papers citing papers by Misato Ito
This network shows the impact of papers produced by Misato Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misato Ito. The network helps show where Misato Ito may publish in the future.
Co-authors
The 25 scholars most cited alongside Misato Ito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 77 | |
| 2 | 2018 | 66 | |
| 3 | 2022 | 24 | |
| 4 | 2002 | 16 | |
| 5 | 2020 | 16 | |
| 6 | 2022 | 12 | |
| 7 | 2023 | 11 | |
| 8 | 2016 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 9 | |
| 13 | 2009 | 7 | |
| 14 | 2016 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2017 | 6 | |
| 17 | 2021 | 6 | |
| 18 | 2020 | 6 | |
| 19 | 2021 | 5 | |
| 20 | 2019 | 5 |
About Misato Ito
Misato Ito is a scholar working on Oncology, Immunology, Organic Chemistry, Molecular Biology and Surgery, having authored 35 papers that have together received 350 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Cytokine Signaling Pathways and Interactions (5 papers), Immune Cell Function and Interaction (4 papers), Radical Photochemical Reactions (4 papers), Genetic factors in colorectal cancer (3 papers), Chemokine receptors and signaling (3 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Quinazolinone synthesis and applications (2 papers). The work is most often cited by research in Oncology (165 citations), Rheumatology (75 citations), Genetics (51 citations), Immunology (84 citations) and Hematology (32 citations). Misato Ito has collaborated with scholars based in Japan. Frequent co-authors include Shohei Shirakami, Takayuki Inoue, Yasuyuki Higashi, Masamichi Inami, Koji Nakamura, Masahiro Murakami, Ayako Moritomo, Yutaka Nakajima, Kazuo Nakai and Hisao Hamaguchi. Their work appears in journals such as Anticancer Research, Cancer Immunology Immunotherapy, Chemistry Letters, Bioorganic & Medicinal Chemistry and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.